Table of Contents: What is non-surgical medical weight loss
Essential documents include your pharmacy history, diagnostic imaging, ER and surgical records, and pathology findings confirming gallbladder disease
The largest psychiatric safety meta-analysis to date found that GLP-1 medications were not associated with increased risk of serious psychiatric adverse events overall ( Pierret et al., JAMA Psychiatry, 2025 ), and a post-hoc analysis of the major semaglutide weight management trials found no differences in depression, suicidal ideation, or suicidal behavior compared to placebo ( Wadden et al., JAMA Internal Medicine, 2024 )
GLP-1 & Muscle Loss: Evidence and Prevention GLP-1 receptor agonists such as semaglutide and liraglutide have transformed weight management for people with obesity, but concerns about muscle loss during treatment are increasingly common
Additionally, LC supplementation enhances blood flow, improves oxygen delivery, and mitigates hypoxia-induced disruptions
